XERS - Xeris Pharmaceuticals EPS misses by $0.05 beats on revenue May, 07 2020 07:14 AM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (NASDAQ:XERS): Q1 GAAP EPS of -$0.89 misses by $0.05.More news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...